GOVXW

GeoVax Labs (GOVXW)

GeoVax Labs Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:GOVXW

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/25	05:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GOVXW	GeoVax Labs Inc
2024/05/24	05:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GOVXW	GeoVax Labs Inc
2024/05/22	06:23	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GOVXW	GeoVax Labs Inc
2024/05/22	01:32	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:GOVXW	GeoVax Labs Inc
2024/05/16	05:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GOVXW	GeoVax Labs Inc
2024/05/15	06:09	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:GOVXW	GeoVax Labs Inc
2024/05/15	06:09	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:GOVXW	GeoVax Labs Inc
2024/05/15	06:08	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:GOVXW	GeoVax Labs Inc
2024/05/15	06:07	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:GOVXW	GeoVax Labs Inc
2024/05/15	05:01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GOVXW	GeoVax Labs Inc
2024/04/05	01:30	GlobeNewswire Inc.	GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine	NASDAQ:GOVXW	GeoVax Labs Inc
2024/03/28	22:00	GlobeNewswire Inc.	GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress	NASDAQ:GOVXW	GeoVax Labs Inc
2024/03/12	22:00	GlobeNewswire Inc.	GeoVax to Present at the 36th Annual Roth Conference	NASDAQ:GOVXW	GeoVax Labs Inc
2024/03/06	23:00	GlobeNewswire Inc.	GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System	NASDAQ:GOVXW	GeoVax Labs Inc
2024/03/01	06:00	GlobeNewswire Inc.	GeoVax Reports 2023 Year-End Financial Results and Provides Business Update	NASDAQ:GOVXW	GeoVax Labs Inc
2024/02/22	23:00	GlobeNewswire Inc.	GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024	NASDAQ:GOVXW	GeoVax Labs Inc
2024/02/19	23:00	GlobeNewswire Inc.	GeoVax to Present at the 2024 BIO CEO & Investor Conference	NASDAQ:GOVXW	GeoVax Labs Inc
2024/02/13	23:00	GlobeNewswire Inc.	GeoVax Announces Multiple Patent Issuances and Allowances	NASDAQ:GOVXW	GeoVax Labs Inc
2024/02/06	23:00	GlobeNewswire Inc.	GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster	NASDAQ:GOVXW	GeoVax Labs Inc
2024/01/29	23:00	GlobeNewswire Inc.	GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement	NASDAQ:GOVXW	GeoVax Labs Inc
2024/01/08	23:00	GlobeNewswire Inc.	GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncology	NASDAQ:GOVXW	GeoVax Labs Inc
2024/01/04	23:00	GlobeNewswire Inc.	GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer Patients	NASDAQ:GOVXW	GeoVax Labs Inc
2024/01/03	23:00	GlobeNewswire Inc.	GeoVax Announces Issuance of Malaria Vaccine Patent	NASDAQ:GOVXW	GeoVax Labs Inc
2023/12/27	23:00	GlobeNewswire Inc.	GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024	NASDAQ:GOVXW	GeoVax Labs Inc
2023/12/19	23:00	GlobeNewswire Inc.	GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox	NASDAQ:GOVXW	GeoVax Labs Inc
2023/12/01	06:30	GlobeNewswire Inc.	GeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine Congress	NASDAQ:GOVXW	GeoVax Labs Inc
2023/11/29	23:00	GlobeNewswire Inc.	GeoVax to Participate in Upcoming December Investor Events	NASDAQ:GOVXW	GeoVax Labs Inc
2023/11/28	23:00	GlobeNewswire Inc.	GeoVax COVID-19 Vaccine Clinical Data Presented at World Vaccine Congress	NASDAQ:GOVXW	GeoVax Labs Inc
2023/11/14	23:00	GlobeNewswire Inc.	Progress on GeoVax’s Universal Coronavirus Vaccine Candidate, GEO-CM02, Presented at Vaccines Summit 2023	NASDAQ:GOVXW	GeoVax Labs Inc
2023/11/09	06:00	GlobeNewswire Inc.	GeoVax Reports Third Quarter 2023 Financial Results and Provides Business Update	NASDAQ:GOVXW	GeoVax Labs Inc